SYNTHOS RESEARCH

Allegion ALLE

Industrials · Security & Protection Services · Synthos Deep Dive · 2026-07-03

$140.58
Watch
Risk 4Growth 6Exponential 3Fair value $172 $125–$205

At a glance

VerdictWatch — systematic Synthos tier
Price (2026-07-02)$140.58 · market cap ~$12.1B
Synthos scores (0–10)Downside Risk 4 · Growth Quality 6 · Exponential Potential 3
Synthos fair value (base case)~$172+22% · full range $125 (bear) – $205 (bull)
Street consensus$162 (high $180 / low $142; 7 Buy · 16 Hold · 0 Sell → "Hold") — context, not our anchor
Valuation19× trailing EPS · 16× FY26E · 15× FY27E · 11× FY29E · EV/S 3.3× · EV/EBITDA 13.8×
Exponential Potential3/10 · Low — a mature door-hardware compounder; ~2–4% organic growth, decelerating, no multibagger runway
TechnicalsMixed — $140.58, −22% off 52-wk high, above 50-DMA ($134) but below 200-DMA ($155), RSI 62, −5% 12-mo (SPY +21%)
ConvictionLow — 0 expert voices, 0 KB claims; this is a quant/fundamentals call, not a panel call
Position sizingSmall tactical value position, ~1–2% — a mispricing, not a core conviction holding
Next catalyst2026-07-23 Q2'26 earnings (Street EPS $2.22)
Single biggest riskCyclical demand — a US non-residential/residential construction downturn hits volumes directly

One-line thesis. Allegion is the boring, high-quality locks-and-door-hardware business behind Schlage, Von Duprin and LCN — 45% gross margin, 32% ROE, steady cash — that the market has marked down 22% from its high on soft volumes and an ERP hiccup; at ~19× trailing and ~15× FY27E earnings it offers a reasonable margin of safety, but with only 2–4% organic growth this is a value-and-quality call, not a growth story, and no expert in our KB is on record either way.

◆ Synthos call — Watch ALLE is a business we want at a price we don't have — it becomes a Buy below ~$155; until then, do nothing.
Downside Risk (lower = safer)
4/10 · Moderate
Low beta (0.88), modest 19× P/E and 13.8× EV/EBITDA, net-debt/EBITDA 1.7× — but cyclical residential/non-resi exposure and stock 22% off its high.
Growth Quality
6/10 · High
High-single-digit revenue and low-double-digit EPS CAGR, 45% gross margin, 32% ROE, wide switching-cost moat — solid, not spectacular.
Exponential Potential
3/10 · Low
Mature mechanical-security compounder; low-single-digit organic growth is decelerating, not accelerating — the electronics/SaaS pivot is real but small.
⚖ Reverse-DCF cross-check Market-implied growth ≈ 15%/yr To justify today’s $141, earnings would have to compound roughly 15% a year for 10 years (9% discount rate). Analysts forecast ~12%/yr, so the market is pricing in MORE than what the Street expects.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

In plain English

Allegion makes locks, door closers and exit devices — the Schlage lock on a front door, the push-bar on a school or hospital exit, the electronic access system in an office. Every building needs them, they wear out and get replaced, and switching brands is a hassle for the builder or facility manager. That gives Allegion a sticky, high-margin, cash-generating business — it keeps about 45 cents of gross profit on every sales dollar and earns a very high return on the money shareholders put in.

The catch: it's a mature, slow grower. Sales rise only a few percent a year in the underlying business, and demand rises and falls with construction and renovation cycles. Right now the stock is cheaper than usual — it's down about 22% from its 12-month high — so you're buying a good business at a fair-to-cheap price. Our verdict is Buy — Tactical: worth owning as a modest value position, but it's a steady tortoise, not a rocket.

Here's what our three scores mean in everyday terms:

The one big worry: Allegion's business follows the building cycle. If new construction and renovation slow — especially US commercial and housing — its volumes drop and so do earnings.

Honesty note: no outside expert we track has published a view on Allegion, so this note leans entirely on the numbers and the company's own filings. We flag that plainly rather than manufacture conviction.


Price & moving averages 12 months · 50 & 200-day averages · 52-week range

121137153168184Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2652w hi $180200-DMA 155Price 14150-DMA 13452w lo $126

Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

117135154172190Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26Price 14120-day avg 134

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

705030Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26RSI 62.0

Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 62.

MACD 12 / 26 / 9 · trend & momentum

0Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26MACD 1.9signal 0.8

Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago

8293105117128Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26XLI (sector) 124S&P 500 120ALLE 95

Solid = ALLE · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

01346$3BFY22EPS $5$4BFY23EPS $6$4BFY24EPS $7$4BFY25EPS $8$4BFY26EEPS $9$5BFY27EEPS $10$5BFY28EEPS $11$5BFY29EEPS $12

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$140.58
Market cap$12B
P/E trailing
P/E FY26E / FY27E16× / 15×
EV / Sales3.3×
EV / EBITDA13.8×
Gross margin45.0%
Net margin15.2%
Dividend yield1.51%
Beta0.875
52-wk range$126 – $180
RSI(14)62
50 / 200-DMA$134 / $155
12-mo return+-5% (SPY +21%)
Street target$162 ($142–$180)
Analyst grades7 Buy · 16 Hold · 0 Sell
FMP ratingB+
Next earnings2026-08-05

What the experts actually said 0 traceable claims on ALLE · showing the highest-conviction voices

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

1. What it is

Allegion plc (NYSE: ALLE) is a Dublin-domiciled, ~$12B global security-hardware maker spun out of Ingersoll Rand in 2013. Its brands — Schlage (locks), Von Duprin (exit devices), LCN (door closers), CISA, Interflex, and SimonsVoss (electronic access) — sit on doors in schools, hospitals, offices, hotels and homes worldwide. The business is replacement- and code-driven (fire/life-safety codes mandate exit devices; locks wear out), which gives it recurring, non-discretionary demand on top of new-construction cycles. Fiscal year ends December 31. CEO John H. Stone; ~13,300 employees.

Revenue mix (FY2025, from filings):

The strategic story is a slow mix-shift from mechanical hardware toward electronic access control and software (SaaS), plus bolt-on M&A (the recent DCI acquisition lifts FY26 reported growth). It is an incremental evolution, not a reinvention.

2. The expert thesis — why the panel is bullish (traceable)

There is no expert thesis to report. The Synthos knowledge base contains zero distilled claims for Allegion (total_claims: 0, breadth 0, net conviction 0). None of the investors, analysts or operators we track has an on-record, traceable view on this name.

That is an honest and common outcome for a mid-cap industrial that sits outside the megacap/AI/biotech spotlight our expert panel gravitates toward. The consequence is stated plainly: every judgment in this note is fundamentals- and quant-driven — built from FMP financials, analyst estimates, the company's own SEC filings, and Synthos's scoring framework. There is no panel conviction to lean on, and we do not pretend otherwise. Conviction is therefore rated Low — not because the business is weak, but because our differentiated edge (the expert KB) is silent here.

Absent expert claims, the external tells we can cite: the sell-side is lukewarm — 7 Buy / 16 Hold / 0 Sell, consensus "Hold" — and the FMP letter rating is B+ (overall score 3/5), strong on ROE/ROA, weak on debt-to-equity and price-to-book. Context, not conviction.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)4 · Low-ModerateBeta 0.88, undemanding 19× trailing / 13.8× EV/EBITDA, net-debt/EBITDA 1.7× (serviceable at 8.5× interest coverage). Offsets: cyclical construction exposure and a stock already −22% off its high.
Growth Quality6 · Solid~9% FY25 revenue growth (much of it M&A/FX; only ~2–4% organic), ~12% forward EPS CAGR, 45% gross margin, 32% ROE, 15.6% ROIC, sticky switching-cost moat. Good business, modest growth.
Exponential Potential3 · LowMature mechanical-hardware compounder; organic growth is low-single-digit and decelerating, not accelerating. The electronics/SaaS pivot is real but small. No multibagger runway.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.

CaseKey assumptionsFair value
BullNon-resi stays firm, electronics/SaaS mix lifts margin, ERP disruption fully recovers, DCI accretes. FY27E EPS beats to ~$10.2 (vs $9.57 cons); multiple re-rates to ~20× as growth quality is rewarded.~$205 (+46%)
Base (our anchor)Estimates roughly hit — FY27E EPS ~$9.57; a durable 45%-GM, 32%-ROE compounder earns a ~18× multiple (its own historical norm).~$172 (+22%)
BearUS construction/renovation downturn; residential volumes fall, price can't fully offset, ERP recovery slips. FY27E EPS misses to ~$8.7; multiple de-rates to ~15×.~$125 (−11%)

Synthos fair value = the base case, ~$172 (+22%), with the full $125–$205 span as the honest range. Our base sits modestly above the Street's $162 consensus (we credit the FY27 earnings power and a return to normal multiple), while our bear brackets the downside near the Street's $142 low. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). Allegion is squarely a mature compounder — the opposite of an exponential:

Exponential Potential: Low (3/10). Own Allegion for steady ~10–13% earnings compounding at a fair price, not for a fast multibagger. A small, accelerating access-control pure-play would score far higher; ALLE is the safe, slow incumbent.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

Allegion is not expensive — the core of the tactical case. On trailing numbers it trades at 19× EPS, 3.3× EV/sales, 13.8× EV/EBITDA — all reasonable for a 45%-GM, 32%-ROE industrial. On forward consensus the P/E steps down to 16× (FY26E $8.78) → 15× (FY27E $9.57) → ~11× (FY29E $12.30) as estimates rise, so the multiple compresses meaningfully even at a flat price if the numbers hit. The catch is why it's cheap: slow organic growth and a soft-volume, ERP-disrupted patch have pulled the stock 22% off its high. A reverse read: at ~$141 the market is pricing roughly the low-single-digit organic / low-double-digit EPS path — i.e., little is expected, which is where the margin of safety comes from. Street targets (context): consensus $162, high $180, low $142; our $172 base FV is modestly above consensus because we credit a return toward the 18× historical multiple on FY27 earnings. Not a bargain-of-a-lifetime; a quality-at-a-fair-price buy.

7. Technicals (from the tech block)

8. Moat & competitive position

Allegion's moat is a switching-cost + specification + brand stack: (1) spec-in and code lock-in — architects and facility managers spec Schlage/Von Duprin/LCN into buildings, and fire/life-safety codes mandate compliant exit devices, so the installed base is sticky; (2) replacement-driven recurring demand — hardware wears out and must match existing keying/systems, favoring the incumbent; (3) brand and channel — leadership in specialty distribution and retail (Schlage is a top consumer lock brand). The competitive frame is an oligopoly with Assa Abloy (the global #1) and dormakaba; the real threat is the shift to electronic/smart access, where newer entrants (and Assa Abloy's scale) compete and where Allegion must keep investing to avoid being disrupted from mechanical into electronic.

Peer set (FMP-supplied, market cap): the list is a grab-bag of mid-cap industrials rather than true door-hardware comps — Avery Dennison $12.8B, Carlisle $14.8B, Graco $12.5B, ITT $16.7B, Textron $16.1B, Watsco $16.7B, Rentokil $15.1B, plus outliers (Joby $8.4B, LATAM $16.5B). The most relevant real competitor, Assa Abloy, is not in the FMP peer list but is the key benchmark. Against the quality-industrial cohort, ALLE screens with above-average margins and ROE at a below-average multiple.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): two consecutive quarters of negative organic growth (not just volume); adjusted operating margin sustained below ~20%; the ERP recovery slipping into 2027; or a break of the 52-week low (~$126) confirming the cyclical-downturn bear case.

11. Key risks

12. Verdict, position sizing & monitoring

Buy — Tactical. Allegion is a genuinely high-quality business — 45% gross margin, 32% ROE, 106% FCF conversion, a sticky code-and-spec moat — that the market has marked down 22% from its high on soft volumes and a fixable ERP hiccup. At ~19× trailing and ~15× FY27E, with management affirming its outlook and buying back $500M of stock, the risk/reward tilts modestly positive: our base case fair value of ~$172 (+22%) offers a reasonable margin of safety. But this is Tactical, not Core for two honest reasons: (1) organic growth is only 2–4% and decelerating — this is a value re-rating story, not a compounding-growth story; and (2) no expert in our KB covers it, so conviction is Low and rests on the numbers alone.


Provenance & disclosures